drugset / Trial / NCT00051168

A Long-term Safety Study of Once-daily Travatan

NCT00051168

Phase 3 Completed 502 enrolled Alcon Research
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.

Timeline

Start
2006-01
Primary completion
2009-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified 0.004 % Topical